From knowledge transfer to tomorrow’s therapeutic approaches

Located in the heart of Paris, the «Voir et Entendre» Carnot Institute represents one of the most important international centers in neurosensory research.

This institute is designed as a place of exchange gathering on the same site patients, clinicians, researchers and industrials in order to accelerate innovation in terms of health products and high technology, while bringing solutions to unmet needs of people impaired by pathologies and handicaps affecting visual and hearing systems.

The Activities Development of therapies (research, developing and running of clinical trials) Sensory restoration (artificial retina, cochlear implants) Innovation in investigation tools (retinal imaging) Overall approaches on issues linked to sensory impairment (urban planning, home automation, services) Medtech Generator & Accelerator

An ecosystem supporting innovation and startups

• Access to 12 technological core facilities for our partners
• Creation of 8 spin-offs by the «Voir et Entendre» Carnot Institute

Our core strategy: partnerships

• Small and medium sized pharma and biotech companies: Sanofi, Pfizer, Novartis, Alcon, Allergan, GenSight Biologics, Santen-Novagali etc...
• Small and medium sized companies in nanomaterials, optics, robotics, electronics: Essilor, Thales, Siemens, Imagine Eyes, Pixium Vision, LLTech etc...
• Research laboratories in life sciences: FMI (Basel), MEEI (Boston), UCL (London), Max Planck Institut (Frankfurt), University of Pittsburgh (USA), Riken Institut of Kobe (Japan) etc...
• Research laboratories in optics, acoustics, robotics, mathematics, signal Transmission: CEA Léti, CEA List, ESPCI, ESIEE etc...
• Clinical research center: member of EVICRNet, a European network of clinical research in ophthalmology (98 members, 15 countries)

• Comment l'Institut Carnot Voir et Entendre veut promouvoir la silver economy et contribuer à la recherche sur le handicap (only available in french)